Copyright (C) intekbio. Co. Ltd. All Rights Reserved.INTEKBIO. Co. Ltd
PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate cancer or other prostate disorders : Prostate cancer is the 1st prevalent & 3rd most deadly cancer for men with newly diagnosed 670K patients per year. Medical use is Prostate cancer screening, Risk stratification and staging, Post-treatment monitoring and Histology meaning (worldwide)
POC PSA test market portion totaled $68M in 2014 and withannual growth of 3.2% will reach $80M by 2019.
Higher growth in the market will be contingent upon the development of advanced PSA markers.